Changeflow GovPing Healthcare & Life Sciences

Latest changes

This category tracks 375 sources on GovPing, spanning Guidance, Enforcement, Rule, FAQ, Notice, and Consultation instruments across 3,281 total sources. There were 1,513 changes in the last 7 days.

The California Board of Pharmacy revoked 12 pharmacy licenses in Q2 2026 and 40+ pharmacy licenses in Q1 2026. The NJ Board of Veterinary Medical Examiners ordered Dr. Gerald Buchoff to pay $7,500 for negligence in treating a Yorkshire Terrier. Health Canada issued a Type I recall for Philips MRI systems over liver stiffness measurement errors.

Favicon for mqa-internet.doh.state.fl.us

State of Florida Pharmacist License Discipline Record

The State of Florida Department of Health has updated the license verification for Pharmacist Traniece Fullwood, indicating a discipline action is on file. This update signifies a change in the professional standing of the licensee.

Priority review Enforcement Healthcare
Favicon for mqa-internet.doh.state.fl.us

Pharmacist John Laud-Hammond Faces Discipline

The Florida Department of Health has imposed disciplinary obligations on pharmacist John Laud-Hammond. The license verification indicates 'Discipline on File' and 'Public Complaint' are present, requiring further review of specific actions taken.

Priority review Enforcement Healthcare
Favicon for doh.wa.gov

Washington Massage Therapist Matthew McQuain Suspended for Sexual Misconduct

WA DOH suspended the massage therapy license of Matthew McQuain (credential MA61548984) in King County following charges that he sexually assaulted two clients during massage therapy sessions. The suspension bars McQuain from practicing as a massage therapist in Washington State pending further legal action. McQuain has 20 days to request a hearing to contest the charges.

Urgent Enforcement Healthcare
Favicon for doh.wa.gov

Washington State Disciplines Healthcare Providers

The Washington State Department of Health has taken disciplinary actions against 14 healthcare providers in February 2026. These actions include denying applications for credentials and rescinding previously issued credentials due to violations and professional misconduct.

Priority review Enforcement Healthcare
Favicon for doh.wa.gov

State Revokes, Suspends Health Care Provider Licenses

The Washington State Department of Health has revoked or suspended the licenses, certifications, or registrations of eight health care providers due to misconduct, including financial exploitation of vulnerable adults and practicing under the influence. Some providers also face fines and indefinite suspension of credentials.

Priority review Enforcement Healthcare
Favicon for doh.wa.gov

King County Massage Therapist License Suspended

Washington State health officials have suspended the license of King County massage therapist Jason Senat pending further legal action. The suspension follows charges alleging sexual assault of four clients and is intended to protect patient safety. Senat has the option to request a hearing to contest the charges.

Urgent Enforcement Healthcare
Favicon for doh.wa.gov

Washington DOH Disciplines Healthcare Providers

The Washington State Department of Health has taken disciplinary actions against nine healthcare providers for misconduct, including unprofessional conduct, financial exploitation, and unlicensed practice. These actions range from charges and investigations to denial of credentials and termination of probation.

Priority review Enforcement Healthcare
Favicon for portal.ct.gov

Pharmacy Commission Meeting Minutes and Actions

The Connecticut Commission of Pharmacy met on October 30, 2024, approving a new pharmacy application with modifications, a pharmacy remodel, and issuing fines totaling $3,000 to Walgreens for violations related to pharmacy closures and compounding standards. The commission also approved reciprocity and new applications.

Priority review Notice Pharmaceuticals
Favicon for portal.ct.gov

Pharmacy Commission Meeting Agenda - October 30, 2024

The Connecticut Pharmacy Commission meeting agenda for October 30, 2024, outlines discussions on new pharmacy applications, remodels, pharmacy manager appointments, and reciprocity interviews. The agenda also includes requests for new non-resident pharmacy applications and updates on previously approved or denied applications.

Routine Notice Pharmaceuticals
Favicon for portal.ct.gov

Pharmacy Commission Meeting Minutes - Approvals and Enforcement

The Connecticut Commission of Pharmacy approved new pharmacy premises and several pharmacy remodels during its November 20, 2024 meeting. The Commission also initiated an enforcement action against Walgreens #02410 for alleged violations related to pharmacy manager changes and operating without a manager.

Priority review Enforcement Pharmaceuticals
Favicon for portal.ct.gov

Pharmacy Commission Meeting Agenda

The Connecticut Pharmacy Commission met on November 20, 2024, to review 20 new pharmacy applications, including new and non-resident pharmacies, and address two legal cases. The agenda also included discussions on pharmacy remodels and reciprocity interviews.

Routine Notice Pharmaceuticals
Favicon for portal.ct.gov

Connecticut Commission of Pharmacy Meeting Schedule

The Connecticut Commission of Pharmacy published its 2025–2026 meeting schedule, listing regular meetings on dates ranging from January 2025 through March 2026. Meetings are held at the Plaza North building in Hartford, CT, with most sessions scheduled from 10:00 AM to 12:30 PM or 1:00 PM. The schedule provides public notice of upcoming commission sessions; agendas, minutes, and video recordings are linked where available.

Routine Notice Healthcare
Favicon for www.dhp.virginia.gov

Virginia Board of Pharmacy Staffing Concerns and Statewide Protocols Update

The Virginia Board of Pharmacy has updated its guidance on reporting pharmacy staffing concerns and has amended several statewide protocols for pharmacists. Pharmacy permit holders must review and act on staffing reports, and pharmacists can report issues directly to the board without fear of retaliation. The revised protocols cover vaccinations, tuberculosis testing, hormonal contraceptives, naloxone, influenza, and strep throat.

Priority review Guidance Pharmaceuticals
Favicon for www.dhp.virginia.gov

Virginia Pharmacy Technician Registration Requirements Updated

The Virginia Board of Pharmacy has issued a notification clarifying updated registration requirements for pharmacy technicians, effective July 1, 2025, pursuant to statute 54.1-3321(B). To be registered as a pharmacy technician, applicants must submit an application and fee, evidence of completing an accredited training program (including programs accredited through the Department of Education's Career and Technical Education program, approved by the Board, recognized by PTCB or NHA, or operated through a federal agency or military branch), and evidence of passing a national certification examination administered by PTCB or NHA.

Routine Notice Healthcare
Favicon for www.dhp.virginia.gov

Virginia Board of Pharmacy Legislative and Regulatory Updates

The Virginia Board of Pharmacy has updated its regulations regarding pharmacy technician education standards and collaborative practice agreements. Key changes include expanded options for technician training and clarified processes for pharmacists to obtain DEA registration for prescribing controlled substances.

Priority review Guidance Pharmaceuticals
Favicon for www.dhp.virginia.gov

Virginia Board of Pharmacy Revised Online PIC Change Process

The Virginia Board of Pharmacy has implemented a revised, entirely online process for completing a change of pharmacist-in-charge (PIC) for pharmacy permits. This update includes electronic payment via credit card and requires uploading a one-page document to finalize the request. A revised Pharmacy Permit Application Form is also now in use for other changes.

Routine Notice Pharmaceuticals
Favicon for www.dhp.virginia.gov

Virginia Pharmacy Law and Regulatory Updates

The Virginia Board of Pharmacy presented updates on recent legislative and regulatory changes affecting pharmacy practice. Key changes include expanded educational standards for pharmacy technicians and new provisions for collaborative practice agreements allowing pharmacists to prescribe certain controlled substances.

Priority review Guidance Pharmaceuticals
Favicon for www.mass.gov

Massachusetts: 90-day Supply for Certain Schedule II/III Prescriptions

The Massachusetts Board of Registration in Pharmacy updated its policy to allow a 90-day supply for certain Schedule II and III prescriptions, including those for opioid use disorder treatment, non-opioid stimulants, testosterone, and implantable infusion pumps. Other Schedule II and III medications remain limited to a 30-day supply.

Priority review Guidance Pharmaceuticals
Favicon for www.mass.gov

MA Board Adopts Rapid Microbial Methods for Sterility Testing

The Massachusetts Board of Registration in Pharmacy has adopted a new policy allowing the use of Rapid Microbial Methods (RMMs) as an alternative for sterility release testing of compounded sterile preparations (CSPs). This policy outlines requirements for licensed sterile compounding pharmacies to ensure public safety when using these advanced technologies.

Priority review Guidance Pharmaceuticals
Favicon for www.mass.gov

Rapid Microbial Methods Sterility Testing Guidance

The Massachusetts Department of Public Health has issued guidance on the use of Rapid Microbial Methods (RMMs) for sterility testing. This document outlines acceptable approaches and considerations for implementing RMMs in pharmaceutical and medical device manufacturing.

Routine Guidance Pharmaceuticals
Favicon for www.mass.gov

Massachusetts Pharmacy Practice Definitions

The Massachusetts Board of Registration in Pharmacy has issued a document defining key terms related to pharmacy practice. This guidance aims to clarify terminology for pharmacists and related entities operating within the state.

Routine Guidance Healthcare
Favicon for www.mass.gov

Pharmacy Policy: Definitions for Automated Dispensing, Compounding, and Events

The Massachusetts Board of Registration in Pharmacy has adopted Policy 2025-02, defining key terms related to automated dispensing devices, automated pharmacy systems, pharmacy processing automation, quality-related events, and serious adverse drug events. These definitions clarify regulatory expectations for pharmacies operating in the state.

Routine Guidance Pharmaceuticals
Favicon for idfpr.illinois.gov

Illinois Department of Financial and Professional Regulation Enforcement Actions April 2025

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in April 2025 against 31 individuals and 10 companies. Actions include consent orders, settlements, and license suspensions related to violations of various state acts.

Priority review Enforcement Employment & Labor
Favicon for idfpr.illinois.gov

Illinois IDFPR January 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) published enforcement actions taken in January 2025 across its Division of Banking, Division of Financial Institutions, and Division of Professional Regulation. Key actions include the FDIC being appointed receiver for Pulaski Savings Bank, a consent order against Block Inc. for Bank Secrecy Act violations, cease and desist orders against unlicensed practitioners with civil penalties up to $10,000, and professional license suspensions spanning cosmetology, dentistry, clinical psychology, and private security for tax delinquency, child support arrears, and conduct violations.

Priority review Enforcement Financial Services
Favicon for idfpr.illinois.gov

IDFPR February 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in February 2025 against 30 entities. Actions include license suspensions, consent orders for violations of various acts, and settlements for late renewal payments.

Priority review Enforcement Financial Services
Favicon for idfpr.illinois.gov

Illinois March 2025 Disciplinary Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in March 2025. Actions include consent orders for unlicensed activity, late renewal payments, reciprocal discipline, and settlements for violations of various acts. Several professional licenses were suspended for failure to pay state income taxes or child support.

Priority review Enforcement Employment & Labor
Favicon for idfpr.illinois.gov

Illinois IDFPR May 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in May 2025 against 21 individuals and 7 companies. Actions include license revocations, consent orders, settlements, and civil penalties for violations of various financial and professional regulations.

Priority review Enforcement Financial Services
Favicon for www.pharmacy.ca.gov

California Board of Pharmacy News Roundup - August 2025

The California Board of Pharmacy issued a news roundup for August 2025, providing updates on Rite Aid closures, emergency refills, medication error reporting requirements effective September 1, 2025, and a new online portal for drug theft/loss reporting. A new Pharmacist-in-Charge training webinar is also available.

Priority review Notice Pharmaceuticals
Favicon for www.pharmacy.ca.gov

California Board of Pharmacy: Vaccine Administration Update

The California Board of Pharmacy issued a news roundup detailing changes to pharmacist authority regarding vaccine administration, effective January 1, 2026, due to Assembly Bill 1503. The update encourages pharmacists to transition to a standard of care practice model for immunizations for patients three years and older.

Priority review Notice Pharmaceuticals
Favicon for www.pharmacy.ca.gov

California Board of Pharmacy December Update: Standard of Care, Vaccines, CAMER

The California Board of Pharmacy's December 2025 update announces the transition of certain pharmacist-provided patient care services, including vaccine administration, to a standard of care model effective January 1, 2026, per AB 1503. It also reminds schools about standing orders for albuterol and epinephrine and mandates reporting medication errors to the CAMER system for events on or after September 1, 2025.

Priority review Notice Pharmaceuticals
Favicon for www.pharmacy.ca.gov

California Board of Pharmacy Updates and AB 1503 Changes

The California Board of Pharmacy is updating its regulations effective January 1, 2026, due to Assembly Bill 1503. Key changes include a transition to a Standard of Care practice model for certain pharmacist-provided services and new requirements for nonresident pharmacies operating in California, effective July 1, 2026.

Priority review Guidance Pharmaceuticals
Favicon for www.pharmacy.ca.gov

California Board of Pharmacy Updates on SCRA, AB 1503, and Nonresident Pharmacies

The California Board of Pharmacy issued a news roundup detailing updates on the Servicemembers Civil Relief Act (SCRA), Assembly Bill 1503 impacting pharmacist practice, and new requirements for nonresident pharmacies. Key changes include the transition of certain pharmacist-provided patient care services to a standard of care model and new PIC designation rules for out-of-state pharmacies operating in California.

Priority review Notice Pharmaceuticals
Favicon for oig.hhs.gov

OIG Audit: Medicaid Agencies Made $207M in Unallowable Payments for Deceased Enrollees

The HHS OIG has released an audit report finding that Medicaid agencies made an estimated $207.5 million in unallowable capitation payments to managed care organizations on behalf of deceased enrollees between July 2021 and June 2022. The report recommends CMS provide agencies with data to recover payments and explore OBBB Act implementation.

Priority review Enforcement Healthcare
Favicon for oig.hhs.gov

Maine Medicaid Autism Services Improper Payments

The HHS OIG has issued a report finding that Maine made at least $45.6 million in improper fee-for-service Medicaid payments for autism services provided to children. The audit identified that all sampled claims were improper or potentially improper, leading to recommendations for refunds and improved provider guidance.

Priority review Enforcement Healthcare
Favicon for oig.hhs.gov

HHS OIG: ACF Can Improve Homeless Youth Services Compliance

The HHS Office of Inspector General (OIG) issued a report finding that the Administration for Children and Families (ACF) can improve services to homeless youth by strengthening grant recipients' compliance with Transitional Living Program (TLP) requirements. The audit found significant documentation gaps in service provision for a large percentage of youth served by TLP grants.

Priority review Guidance Social Services
Favicon for oig.hhs.gov

HHS OIG: Hospital Cybersecurity Controls Need Improvement

The HHS Office of Inspector General (OIG) issued a report finding that a large southeastern hospital needs to improve its cybersecurity controls, particularly for web applications. The OIG made four recommendations to enhance defenses against cyberattacks, which the hospital has concurred with.

Priority review Guidance Healthcare
Favicon for oig.hhs.gov

Philadelphia K-12 Schools COVID-19 Testing Program Audit

The HHS Office of Inspector General found that Philadelphia did not consistently monitor its COVID-19 screening testing program for K-12 schools, leading to $257,620 in unallowable costs and overpayments. The OIG recommended Philadelphia update its procedures for oversight and compliance.

Priority review Enforcement Public Health

Showing 7201–7237 of 7,237 changes

1 143 144 145
RSS

Get daily alerts for healthcare & life sciences

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Filters

375 official sources tracked

USPTO Trademarks - Medical Services (Class 044)

Updated 17d ago

ClinicalTrials.gov Studies

Updated 18m ago

USPTO Patent Grants - Diagnosis & Surgery (A61B)

Updated 14m ago

USPTO Trademarks - Medical Devices (Class 010)

Updated 17d ago

USPTO Trademarks - Pharmaceuticals (Class 005)

Updated 17d ago

USPTO Patent Applications - Pharma (A61K)

Updated 7d ago

Regs.gov: Food and Drug Administration

Updated 2d ago

JD Supra Healthcare

Updated 15m ago

USPTO Patent Grants - Prosthetics (A61F)

Updated 25m ago

USPTO Patent Applications - Medical Devices (A61M)

Updated 7d ago

USPTO Patent Applications - Prosthetics (A61F)

Updated 7d ago

USPTO Patent Applications - Biotech (C12N)

Updated 6d ago

USPTO Patent Grants - Therapeutics (A61P)

Updated 25m ago

USPTO Patent Applications - Peptides (C07K)

Updated 7d ago

USPTO Patent Applications - Organic Chemistry (C07D)

Updated 9d ago

USPTO Patent Grants - Organic Chemistry (C07D)

Updated 13m ago

USPTO Patent Grants - Peptides (C07K)

Updated 14m ago

USPTO Patent Applications - Therapeutics (A61P)

Updated 7d ago

USPTO Patent Applications - Health Informatics (G16H)

Updated 10d ago

USPTO Patent Applications - Diagnosis & Surgery (A61B)

Updated 18d ago

ANSM Drug & Device Safety Alerts

Updated 1h ago

FR: National Institutes of Health

Updated 43m ago

Regs.gov: Centers for Medicare and Medicaid Services

Updated 32m ago

FR: Health and Human Services Department

Updated 1h ago

Health Canada Recalls & Safety Alerts

Updated 31m ago

FR: Food and Drug Administration

Updated 2d ago

EPO Patent Bulletin - Pharma (A61K)

Updated 1d ago

EPO Patent Bulletin - Biotech (C12N)

Updated 1d ago

EPO Patent Bulletin - Health Informatics (G16H)

Updated 1d ago

USPTO Patent Grants - Medical Devices (A61M)

Updated 3d ago

South Carolina DPH News

Updated 16m ago

USPTO Patent Grants - Health Informatics (G16H)

Updated 1d ago

EPO Patent Bulletin - Diagnosis & Surgery (A61B)

Updated 1d ago

EPO Patent Bulletin - Medical Devices (A61M)

Updated 4d ago

WHO News

Updated 2d ago

FR: Centers for Disease Control and Prevention

Updated 26m ago

Hawaii DOH News

Updated 7d ago

CMS Newsroom

Updated 10d ago

FR: Centers for Medicare & Medicaid Services

Updated 2d ago

IN Dept of Health

Updated 19m ago

FR: Children and Families Administration

Updated 3d ago

Regs.gov: Drug Enforcement Administration

Updated 17d ago

NY DOH Press Releases 2026

Updated 3d ago

Regs.gov: Administration of Children and Families

Updated 12d ago

FDA Medical Device Recalls

Updated 4d ago

HSA Singapore Announcements

Updated 1h ago

Oregon OHA News

Updated 4d ago

DEA Press Releases

Updated 3d ago

North Carolina DHHS News

Updated 3d ago

USPTO Patent Grants - Biotech (C12N)

Updated 26m ago

Wales CIW News

Updated 22m ago

EPO Patent Bulletin - Organic Chemistry (C07D)

Updated 3d ago

EPO Patent Bulletin - Peptides (C07K)

Updated 20h ago

Louisiana LDH News

Updated 27m ago

Medicaid State Plan Amendments

Updated 20d ago

DEA Public Safety Alerts

Updated 4d ago

MT Dept of Public Health News

Updated 10m ago

Saudi SFDA News

Updated 6d ago

Kansas KDHE Health News

Updated 36m ago

Michigan DHHS News

Updated 16m ago

Get Healthcare & Life Sciences alerts

Daily digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get Healthcare & Life Sciences alerts

We'll email you when new healthcare & life sciences changes are detected.

Free. Unsubscribe anytime.

You're subscribed!